HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Marketing In Brief

This article was originally published in The Rose Sheet

Executive Summary

Narciso Rodriguez: Designer's her eau de parfum will debut in Saks Fifth Avenue stores this month, Beaute Prestige International says. Scent will additionally roll out in Bloomingdales's and Nordstrom in mid-September, two years after debut of original fragrance, an eau de toilette featuring orange and osmanthus blossoms, amberlyn, vanilla and vetiver accords (1"The Rose Sheet" July 7, 2003, p. 6). Scents share a heart of musk with floral, amber and woods, but edp version includes notes of rose and peach pulp, soft amber, patchouli and sandalwood, creating a "more intense, more personal, more singularly sensual" fragrance, according to BPI. Like the original, edp is housed in a rectangular bottle painted from within and intended to resemble an ancient Chinese snuff bottle, but the color scheme is reversed so the parfum comes in a pale pink bottle with black lettering. Her 1.7 oz. edp retails for $70...

You may also be interested in...



New Products In Brief

Transdel: La Jolla, Calif.-based pharmaceutical company developing non-invasive, topically administered medications says it may be able to generate revenue this year by expanding its development program to include cosmetics/cosmeceuticals. Products would feature the same patented Transdel transdermal delivery system used in the start-up's lead product - Ketotransdel, a topical cream-based non-steroidal anti-inflammatory drug - which currently is in Phase III trials for acute pain. Transdel says it has initiated discussions with potential sales and marketing partners for specific cosmetic products

New Products In Brief

Transdel: La Jolla, Calif.-based pharmaceutical company developing non-invasive, topically administered medications says it may be able to generate revenue this year by expanding its development program to include cosmetics/cosmeceuticals. Products would feature the same patented Transdel transdermal delivery system used in the start-up's lead product - Ketotransdel, a topical cream-based non-steroidal anti-inflammatory drug - which currently is in Phase III trials for acute pain. Transdel says it has initiated discussions with potential sales and marketing partners for specific cosmetic products

Designers McCartney, Rodriguez To Launch Premier Scents This Fall

YSL Beaute will launch fashion designer Stella McCartney's premier fragrance,Stella, as a scent that reflects the "contrasts and contradictions" of the designer's ready-to-wear collection, the Gucci division announced

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013207

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel